RESUMEN
The human genome encodes a gene for an enzymatically active chitinase (CHIT1) located in a single copy on Chromosome 1, which is highly expressed by activated macrophages and in other cells of the innate immune response. Several dysfunctional mutations are known in CHIT1, including a 24-bp duplication in Exon 10 causing catalytic deficiency. This duplication is a common variant conserved in many human populations, except in West and South Africans. Thus it has been proposed that human migration out of Africa and the consequent reduction of exposure to chitin from environmental factors may have enabled the conservation of dysfunctional mutations in human chitinases. Our data obtained from 85 indigenous Amerindians from Peru, representative of populations characterized by high prevalence of chitin-bearing enteroparasites and intense entomophagy, reveal a very high frequency of the 24-bp duplication (47.06%), and of other single nucleotide polymorphisms which are known to partially affect enzymatic activity (G102S: 42.7% and A442G/V: 25.5%). Our finding is in line with a founder effect, but appears to confute our previous hypothesis of a protective role against parasite infection and sustains the discussion on the redundancy of chitinolytic function.
Asunto(s)
Quitina/química , Hexosaminidasas/genética , Inmunidad Innata/genética , Animales , Quitina/genética , Dieta , Hexosaminidasas/deficiencia , Humanos , Indígenas Sudamericanos , Macrófagos/metabolismo , Macrófagos/parasitología , Mutación , Parásitos/química , Parásitos/metabolismo , Perú , Polimorfismo de Nucleótido SimpleRESUMEN
BACKGROUND AND PURPOSE: Mutations in the SACS gene are commonly associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a complex neurodegenerative disorder characterized by progressive degeneration of the cerebellum and spinal cord tracts. The aim of this study was to identify the genetic cause of the disease in an Italian family with spastic paraplegia and peripheral neuropathy. METHODS: Affected subjects were subjected to a comprehensive neurological examination including electromyography and brain magnetic resonance imaging. Genetic studies included exclusion of known disease genes, genome-wide linkage analysis using high density single nucleotide polymorphism genotyping and candidate gene sequencing. RESULTS: Molecular analyses revealed a novel missense mutation in the SACS gene (c.11,104A>G) occurring in a homozygous state in patients and absent in 700 Italian control chromosomes. The mutation led to the amino acid substitution p.Thr3702Ala in the sacsin protein, in a possible protein-protein interaction site of UBE3A binding domain. CONCLUSION: This study broadens the genetic spectrum of SACS mutations and expands the clinical ARSACS phenotype suggesting that the SACS gene can be considered in patients with non-canonical ARSACS clinical presentations.
Asunto(s)
Consanguinidad , Proteínas de Choque Térmico/genética , Espasticidad Muscular/genética , Paraplejía/genética , Enfermedades del Sistema Nervioso Periférico/genética , Ataxias Espinocerebelosas/congénito , Adulto , Homocigoto , Humanos , Italia , Masculino , Persona de Mediana Edad , Mutación Missense/genética , Linaje , Fenotipo , Ataxias Espinocerebelosas/genéticaAsunto(s)
Encefalopatías/genética , Enfermedad de Charcot-Marie-Tooth/genética , Proteínas de la Membrana/genética , Proteínas Mitocondriales/genética , Mutación/genética , Empalme del ARN/genética , Encefalopatías/complicaciones , Enfermedad de Charcot-Marie-Tooth/complicaciones , Salud de la Familia , Femenino , GTP Fosfohidrolasas , Humanos , Intrones/genética , Persona de Mediana EdadRESUMEN
The impact of genetics and genomics on clinical medicine is becoming more and more important. Endocrinology pioneered the development of molecular medicine, but also the study of adrenal tumors had a great impact in this field. Particularly important was the detection of genetics of tumors derived from the adrenal medulla, as well as that of those derived from the sympathetic and parasympathetic paraganglia. The identification of mutations in one of the several pheochromocytoma/paraganglioma susceptibility genes may indicate a specific clinical management drive. Less well understood is the genetics of adrenal cortex tumors, in particular adrenocortical carcinoma, a rare and particularly aggressive disease. There are only a few examples of hereditary transmission of adrenocortical carcinoma, but the analysis of low penetrance genes by genome wide association study may enable us to discover new genetic mechanisms responsible for adrenocortical-derived tumors.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/genética , Biomarcadores de Tumor/genética , Mutación , Feocromocitoma/genética , Neoplasias de la Corteza Suprarrenal/genética , Neoplasias de las Glándulas Suprarrenales/patología , Carcinoma Corticosuprarrenal/genética , Predisposición Genética a la Enfermedad , Genómica , Humanos , Proteínas de Neoplasias/genética , Paraganglioma/genética , Feocromocitoma/patologíaRESUMEN
BACKGROUND: Hereditary spastic paraplegia (HSP) with thin corpus callosum (HSP-TCC) is a frequent subtype of complicated HSP clinically characterised by slowly progressive spastic paraparesis with cognitive impairment and thin corpus callosum (TCC). SPG11, the gene associated with the major locus involved, encodes spatacsin, a protein of unknown function. METHODS: Different types of mutations were identified in patients with the complex form of HSP (cHSP) including TCC. We screened a series of 45 index patients with different types of cHSP with (n = 10) and without (n = 35) TCC. RESULTS: Ten mutations, of which five are novel, were detected in seven patients. Of importance, three out of seven mutated patients present with cHSP without TCC. Among the novel mutations identified, we characterised a large intragenic rearrangement deleting 2.6 kb of the SPG11 gene. The rearrangement is due to non-allelic homologous recombination between Alu sequences flanking the breakpoints. CONCLUSIONS: These findings expand the mutation spectrum of SPG11 and suggest that SPG11 mutations may occur more frequently in familial than sporadic forms of cHSP without TCC. This helps to define further clinical and molecular criteria for a correct diagnosis of the SPG11 related form of cHSP. In addition, the intragenic deletion detected here, and the mechanism involved, both provide clues to address the issue of SPG11 missing mutant alleles previously reported.
Asunto(s)
Agenesia del Cuerpo Calloso , Mutación Puntual , Proteínas/genética , Eliminación de Secuencia , Paraplejía Espástica Hereditaria/genética , Secuencia de Aminoácidos , Secuencia de Bases , Análisis Mutacional de ADN/métodos , ADN Intergénico/genética , Salud de la Familia , Femenino , Frecuencia de los Genes , Humanos , Masculino , Datos de Secuencia Molecular , Linaje , Homología de Secuencia de Aminoácido , Paraplejía Espástica Hereditaria/patologíaRESUMEN
Schizophrenia (SZ) and bipolar disorder (BPD) are two severe psychiatric diseases with a strong genetic component. In agreement with the 'continuum theory', which suggests an overlap between these disorders, the existence of genes that affect simultaneously susceptibility to SZ and BPD has been hypothesized. In this study we performed a 7.5 cM genome scan in a sample of 16 families affected by SZ and BPD, all originating from the same northeast Italian population. Using both parametric and non-parametric analyses we identified linkage peaks on four regions (1p, 1q, 4p and 15q), which were then subjected to a follow-up study with an increased marker density. The strongest linkage was obtained on chromosome 15q26 with a non-parametric linkage of 3.05 for marker D15S1014 (nominal P=0.00197). Interestingly, evidence for linkage with the same marker has been reported previously by an independent study performed on SZ and BPD families from Quebec. In this region, the putative susceptibility gene ST8SIA2 (also known as SIAT8B) was recently associated with SZ in a Japanese sample. However, our allele frequency analyses of the two single-nucleotide polymorphisms (SNPs) with putative functional outcome (rs3759916 and rs3759914) suggest that these polymorphisms are unlikely to be directly involved in SZ in our population. In conclusion, our results support the presence of a gene in 15q26 that influences the susceptibility to both SZ and BPD.
Asunto(s)
Trastorno Bipolar/genética , Cromosomas Humanos Par 15 , Ligamiento Genético , Genómica , Esquizofrenia/genética , Mapeo Cromosómico , Femenino , Estudios de Seguimiento , Frecuencia de los Genes , Marcadores Genéticos , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Italia , MasculinoRESUMEN
A novel missense mutation of the L1CAM gene (Xq28) is described in an adult patient affected with severe mental retardation, spastic paraparesis, adducted thumbs, agenesis of corpus callosum and microcephaly (L1 disease). We detected a transition c2308G-->A in exon 18 that caused an amino acid change in codon 770. The patient's mother and two sisters were heterozygous for the same mutation. This newly described mutation predicts the substitution of an aspartate by asparagine (D770N) in the second fibronectin (Fn2) domain of the extracellular portion of the mature L1 protein. Even if amino acid substitution does not significantly change the physico-chemical properties of the Fn2 domain, it seems clear that the integrity of this domain is required to maintain the biological functions of the protein. The feature peculiar to this patient is the decelerated head growth post-natally, leading to microcephaly. Mutations of L1CAM associated with prolonged survival may hamper post-natal brain and head growth.
Asunto(s)
Anomalías Múltiples/genética , Encéfalo/anomalías , Molécula L1 de Adhesión de Célula Nerviosa/genética , Adolescente , Adulto , Secuencia de Bases , Niño , Humanos , Imagen por Resonancia Magnética , Masculino , Mutación Missense , LinajeAsunto(s)
GTP Fosfohidrolasas/genética , Mutación Missense , Mutación Puntual , Paraplejía Espástica Hereditaria/genética , Adolescente , Adulto , Edad de Inicio , Sustitución de Aminoácidos , Niño , Preescolar , Exones/genética , Femenino , Proteínas de Unión al GTP , Trastornos Neurológicos de la Marcha/genética , Humanos , Lactante , Escala de Lod , Masculino , Proteínas de la Membrana , Linaje , Paraplejía Espástica Hereditaria/diagnóstico , Paraplejía Espástica Hereditaria/epidemiologíaRESUMEN
In this study we developed an in situ protocol for quantitative detection of high-risk human papillomavirus (HPV), based on direct in situ polymerase chain reaction (PCR) with SYBR Green I labeling and GeneAmp 5700 Sequence Detection System technology. This protocol was applied on cytological specimens of patients with cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC). We performed direct in situ quantitative PCR on cell smears, uninfected human skin fibroblasts, Hela and Caski cells. After in situ amplification, slides were counterstained with propidium iodide and analyzed under a fluorescent microscope in order to localize high-risk HPV and verify preservation of morphology. After PCR optimization, we obtained the following results. The Hela cells showed values ranging from 15 to 33 copies of high-risk HPV per cell, the Caski cell line from 220 to 300 high-risk HPV copies per cell and the cell smear (both CIN and SCC) around 20-35 copies of high-risk HPV per cell. No high-risk HPV amplification was detected in uninfected human fibroblasts, healthy controls, non-amplification control, and non-specific primer control. A positive intranuclear high-risk HPV amplification was detected in cell smears from 20 patients with CIN and 10 with SCC. In conclusion, our in situ quantitative protocol for high-risk HPV detection on cell smears combines both quantitative data and in situ localization of the target, with preservation of morphology. For this reason it could be used as a rapid screening tool when both morphological and quantitative results are requested on the same slide.
Asunto(s)
Carcinoma de Células Escamosas/virología , Colorantes Fluorescentes/metabolismo , Compuestos Orgánicos , Papillomaviridae/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Displasia del Cuello del Útero/virología , Neoplasias del Cuello Uterino/virología , Benzotiazoles , Diaminas , Femenino , Células HeLa , Humanos , Hibridación Fluorescente in Situ , Papillomaviridae/genética , Quinolinas , Sensibilidad y Especificidad , Células Tumorales CultivadasRESUMEN
Hereditary spastic paraplegias (HSPs), a group of neurodegenerative disorders that cause progressive spasticity of the lower limbs, are characterized by clinical and genetic heterogeneity. To date, three loci for autosomal recessive HSP have been mapped on chromosomes 8p, 16q, and 15q. After exclusion of linkage at these loci, we performed a genomewide search in a consanguineous Italian family with autosomal recessive HSP complicated by mild mental retardation and distal motor neuropathy. Using homozygosity mapping, we obtained positive LOD scores for markers on chromosome region 3q27-q28, with a maximum multipoint LOD score of 3.9 for marker D3S1601. Haplotype analysis allowed us to identify a homozygous region (4.5 cM), flanked by markers D3S1580 and D3S3669, that cosegregates with the disease. These data strongly support the presence, on chromosome 3q27-28, of a new locus for complicated recessive spastic paraplegia, which we have named "SPG14."